NOTCH1 and lymphoma: The oncogenic synergy between NOTCH1 and Bcl2 in this model suggests genetic modifier screens may reveal other genes that interact with NOTCH1 to promote T-ALL.46 All of these rag2 promoter-driven transgenic zebrafish models are amenable to drug and genetic screening to identify individualized treatment strategies for leukemia and lymphoma patients.